Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety and Bioimaging Trial of KB004 in Patients With Glioblastoma

NCT03374943 is registered in ClinicalTrials.gov with Olivia Newton-John Cancer Research Institute as lead sponsor.

NCT NCT03374943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety and Bioimaging Trial of KB004 in Patients With Glioblastoma
Lead sponsor
Olivia Newton-John Cancer Research Institute
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2017
Completion date
September 22, 2021
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma